No profile data available.
Bluejay Diagnostics, Inc. (BJDX) is a healthcare company in the chemical laboratory testing equipment industry, based in Acton, United States, with about 6 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$6.85 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $0. Its market capitalization was $3.68 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. , biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings.
Bluejay Diagnostics reported $0 in revenue for fiscal year 2025. In Q1 2026 revenue was $0.
$3.68 million as of October 9, 2026.
Listed companies of a similar size in the same industry (chemical laboratory testing equipment) include Anbio Biotechnology (NNNN), DarioHealth Corp. (DRIO), Intelligent Bio Solutions Inc. (INBS), Axim Biotechnologies, Inc. (AXIM).